How do I switch from sublingual to injectable Tirzepatide with Direct Meds?

How do I switch from sublingual to injectable Tirzepatide with Direct Meds?

Some patients may wish to request changes to the form of their medication, such as moving from a sublingual formulation to an injectable option. Any change to your medication must be reviewed and approved by a licensed healthcare provider. You can submit a request through your Direct Meds patient portal.

For Patients in the United States

  1. Log in to your Direct Meds portal:https://portal.directmeds.com
  2. Select the Dosage / Medication Change Request option.
  3. Your request will be reviewed by a licensed healthcare provider, who will determine whether any changes are appropriate for your individual treatment plan. Response times are typically within 48 hours, though this may vary.

For Patients in Canada

  1. Log in to the Canadian Direct Meds portal: https://caportal.direct-meds.com/user
  2. Use the available option to request a refill or submit a medication-change request.
  3. In many cases, an existing subscription must be canceled before a new medication type or dosage can be processed. Instructions will be provided within your portal.
Info
If you need help navigating the portal or locating the appropriate request option, the Direct Meds support team is available to assist.
Notes
Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies under medical supervision and may differ in formulation, dosing, and supporting evidence from FDA-approved products.
Alert
This article is for general informational purposes only and does not provide medical advice, diagnosis or treatment for any specific person.